Cancer News and Research

Latest Cancer News and Research

Blocking pathway for generating energy can kill cancer cells

Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

18 Aug 2011

EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.

18 Aug 2011

Celgene expands share repurchase program

Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.

18 Aug 2011

New leukemia drug in early clinical testing offers some clues for better treatment

While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.

18 Aug 2011

U.S. research collaboration addresses threat of cancer in Latin America

In a post in the State Department's "DipNote" blog, Krysten Carrera, a Presidential Management fellow at the National Cancer Institute currently serving in the Bureau of International Organization Affairs, discusses "the growing international effort to address the threat of chronic non-communicable diseases."

18 Aug 2011

Premera, Cord Blood America partner to offer discount on stem cell collection services

Cord Blood America, Inc. today announced that it has entered into an agreement with Premera Blue Cross, a leading health plan provider with operations in Mountlake Terrace, Seattle and Spokane, Washington, and Anchorage, Alaska, and more than 1.4 million members, to store umbilical cord blood at a discounted rate consistent with other Blue Cross licensee contracts.

18 Aug 2011

Herbal supplements may weaken the effect of chemotherapy drugs

Acai berry, cumin, herbal tea, turmeric and long-term use of garlic - all herbal supplements commonly believed to be beneficial to your health - may negatively impact chemotherapy treatment according to a new report presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this summer.

18 Aug 2011

Advanced ROS selects RayStation for conventional 3D-CRT treatments

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Advanced Radiation Oncology Services in Nyack, New York.

18 Aug 2011

New process may eliminate need for full genome sequencing for cancer patients

People at risk for a certain form of colon and other types of cancer may soon have a better chance at surviving or even avoiding the diseases, thanks to a new study done by the Intermountain Clinical Genetics Institute at LDS Hospital.

18 Aug 2011

Medicare Advantage plans may be counter-productive for the elderly

In health care, more choice may not always lead to better choices, particularly for the elderly. In a new study, researchers from Harvard Medical School's Department of Health Care Policy found that the large variety of managed care plans offered by the Medicare Advantage program may be counter-productive.

18 Aug 2011

Majority of physicians continue to recommend annual cervical cancer screening

Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study

Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.

18 Aug 2011

Scientists turn drug-disease match makers

In a new medical breakthrough American researchers have devised a drug-disease matchmaking program that mines databases for potentially useful new treatment combinations and have actually turned up two so far, said a study on Wednesday.

18 Aug 2011

Human embryonic stem cell, iPS-derived progeny are similar and developmentally immature

Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.

18 Aug 2011

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

A new drug was approved for advanced skin cancer this Wednesday by U.S. regulators, offering the first new treatment for melanoma in 13 years.

18 Aug 2011

FDA approves Mayo Clinic's ovarian and breast cancer vaccines

Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells.

18 Aug 2011

NCRM at Case Western Reserve to host stem cell conference in Cleveland

The National Center for Regenerative Medicine (NCRM) at Case Western Reserve University is proud to present "MSC 2011: Innovations in Cell-Based Regenerative Therapies," a three-day forum to highlight transformative breakthroughs in the area of adult stem cell medicine with a focus on how this research is being applied in patient care settings through innovative clinical trials.

18 Aug 2011

Clinical trials to evaluate and validate infrastructure of P-medicine consortium

Retrospective and prospective clinical trials will be run to evaluate and validate the infrastructure of the P-medicine consortium, announced a poster at the recent 3rd symposium of the Worldwide Innovative Networking in Personalized Cancer Medicine, held in Paris 6-8 July, 2011.

18 Aug 2011

GOP presidential hopefuls — at least the ones who were or are governors — have clear health care positions

ABC News examines the health policy records of three GOP presidential candidates — former Massachusetts Gov. Mitt Romney, former Utah Gov. Jon Huntsman and Texas Gov. Rick Perry.

18 Aug 2011

Cancer News and Research

Latest Cancer News and Research

Blocking pathway for generating energy can kill cancer cells

EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas

Celgene expands share repurchase program

New leukemia drug in early clinical testing offers some clues for better treatment

U.S. research collaboration addresses threat of cancer in Latin America

Premera, Cord Blood America partner to offer discount on stem cell collection services

Herbal supplements may weaken the effect of chemotherapy drugs

Advanced ROS selects RayStation for conventional 3D-CRT treatments

New process may eliminate need for full genome sequencing for cancer patients

Medicare Advantage plans may be counter-productive for the elderly

Majority of physicians continue to recommend annual cervical cancer screening

Researchers isolate 17 novel antibodies against HIV

Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study

Scientists turn drug-disease match makers

Human embryonic stem cell, iPS-derived progeny are similar and developmentally immature

FDA approves Zelboraf (vemurafenib) for advanced skin cancer

FDA approves Mayo Clinic's ovarian and breast cancer vaccines

NCRM at Case Western Reserve to host stem cell conference in Cleveland

Clinical trials to evaluate and validate infrastructure of P-medicine consortium

GOP presidential hopefuls — at least the ones who were or are governors — have clear health care positions

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in